Abstract
Purpose
Wolfram syndrome (WS) is a rare genetic disorder described by a pattern of clinical manifestations such as diabetes mellitus, diabetes insipidus, optic nerve atrophy, sensorineural hearing loss, urinary tract abnormalities, and psychiatric disorders. WFS1 and WFS2 loci are the main genetic loci associated with this disorder.
Methods
In the current study, we investigated associations between these loci and WS via STR markers and homozygosity mapping in 13 Iranian families with WS. All families were linked to WFS1 locus.
Results
Mutation analysis revealed four novel mutations (Q215X, E89X, S168Del, and E391Sfs*51) in the assessed families. Bioinformatics tools confirmed the pathogenicity of the novel mutations. Other identified mutations were previously reported in other populations for their pathogenicity.
Conclusions
The current study adds to the mutation repository of WS and shows a panel of mutations in Iranian population. Such panel would facilitate genetic counseling and prenatal diagnosis in families with WS cases.
Similar content being viewed by others
References
T. Hershey, H.M. Lugar, J.S. Shimony, J. Rutlin, J.M. Koller, D.C. Perantie, A.R. Paciorkowski, S.A. Eisenstein, M.A. Permutt, Washington University Wolfram Study, G.: early brain vulnerability in Wolfram syndrome. PloS ONE 7(7), e40604 (2012). https://doi.org/10.1371/journal.pone.0040604
R.G. Swift, D.B. Sadler, M. Swift, Psychiatric findings in Wolfram syndrome homozygotes. Lancet 336(8716), 667–669 (1990)
S. Mozafarpour, A.M. Kajbafzadeh, A. Mojtahed, M. Mojtahed, H. Mahboubi, K. Shalileh, Management of bladder dysfunction in Wolfram syndrome with Mitrofanoff appendicovesicostomy: long-term follow-up. J. Pediatr. Surg. (2014). https://doi.org/10.1016/j.jpedsurg.2014.09.058
M. Sobhani, M.A. Tabatabaiefar, A. Rajab, A.M. Kajbafzadeh, M.R. Noori-Daloii, Significant expressivity of Wolfram syndrome: phenotypic assessment of two known and one novel mutation in the WFS1 gene in three Iranian families. Mol. Biol. Rep. 41(11), 7499–7505 (2014). https://doi.org/10.1007/s11033-014-3642-3
H. Inoue, Y. Tanizawa, J. Wasson, P. Behn, K. Kalidas, E. Bernal-Mizrachi, M. Mueckler, H. Marshall, H. Donis-Keller, P. Crock, D. Rogers, M. Mikuni, H. Kumashiro, K. Higashi, G. Sobue, Y. Oka, M.A. Permutt, A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat. Genet. 20(2), 143–148 (1998). https://doi.org/10.1038/2441
T.M. Strom, K. Hortnagel, S. Hofmann, F. Gekeler, C. Scharfe, W. Rabl, K.D. Gerbitz, T. Meitinger, Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum. Mol. Genet 7(13), 2021–2028 (1998). https://doi.org/10.1093/hmg/7.13.2021
G. Boutzios, S. Livadas, E. Marinakis, N. Opie, F. Economou, E. Diamanti-Kandarakis, Endocrine and metabolic aspects of the Wolfram syndrome. Endocrine 40(1), 10–13 (2011). https://doi.org/10.1007/s12020-011-9505-y
J. Kawano, R. Fujinaga, K. Yamamoto-Hanada, Y. Oka, Y. Tanizawa, K. Shinoda, Wolfram syndrome 1 (Wfs1) mRNA expression in the normal mouse brain during postnatal development. Neurosci. Res. 64(2), 213–230 (2009). https://doi.org/10.1016/j.neures.2009.03.005
J. Grenier, I. Meunier, V. Daien, C. Baudoin, F. Halloy, B. Bocquet, C. Blanchet, C. Delettre, E. Esmenjaud, A. Roubertie, G. Lenaers, C.P. Hamel, WFS1 in optic neuropathies: mutation findings in nonsyndromic optic atrophy and assessment of clinical severity. Ophthalmology 123(9), 1989–1998 (2016). https://doi.org/10.1016/j.ophtha.2016.05.036
M. Sobhani, M.A. Tabatabaiefar, A. Rajab, A.M. Kajbafzadeh, M.R. Noori-Daloii, Molecular characterization of WFS1 in an Iranian family with Wolfram syndrome reveals a novel frameshift mutation associated with early symptoms. Gene 528(2), 309–313 (2013). https://doi.org/10.1016/j.gene.2013.06.040
T.G. Barrett, M. Scott-Brown, A. Seller, A. Bednarz, K. Poulton, J. Poulton, The mitochondrial genome in Wolfram syndrome. J. Med. Genet. 37(6), 463–466 (2000)
Y. Noguchi, T. Yashima, A. Hatanaka, M. Uzawa, M. Yasunami, A. Kimura, K. Kitamura, A mutation in Wolfram syndrome type 1 gene in a Japanese family with autosomal dominant low-frequency sensorineural hearing loss. Acta Otoaryngol. 125(11), 1189–1194 (2005)
K.A. Pickett, R.P. Duncan, A.R. Paciorkowski, M.A. Permutt, B. Marshall, T. Hershey, G.M. Earhart; Washington University Wolfram Study, G., Balance impairment in individuals with Wolfram syndrome. Gait posture 36(3), 619–624 (2012). https://doi.org/10.1016/j.gaitpost.2012.06.008
T. Barrett, S. Bundey, A. Macleod, Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 346(8988), 1458–1463 (1995)
M. Saadat, M. Ansari-Lari, D.D. Farhud, Consanguineous marriage in Iran. Ann. Hum. Biol. 31(2), 263–269 (2004). https://doi.org/10.1080/03014460310001652211
S. Ari, U. Keklikci, I. Caca, K. Unlu, H. Kayabasi, Wolfram syndrome: case report and review of the literature. Compr. Ther. 33(1), 18–20 (2007)
M. Al-Till, N.S. Jarrah, K.M. Ajlouni, Ophthalmologic findings in fifteen patients with Wolfram syndrome. Eur. J. Ophthalmol. 12(2), 84–88 (2002)
A. Cano, L. Molines, R. Valero, G. Simonin, V. Paquis-Flucklinger, B. Vialettes; French Group of Wolfram, S., Microvascular diabetes complications in Wolfram syndrome (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness [DIDMOAD]): an age- and duration-matched comparison with common type 1 diabetes. Diabetes Care 30(9), 2327–2330 (2007). https://doi.org/10.2337/dc07-0380
J. Rohayem, C. Ehlers, B. Wiedemann, R. Holl, K. Oexle, O. Kordonouri, G. Salzano, T. Meissner, W. Burger, E. Schober, A. Huebner, M.A. Lee-Kirsch, Wolfram syndrome diabetes writing, G.: diabetes and neurodegeneration in Wolfram syndrome: a multicenter study of phenotype and genotype. Diabetes Care 34(7), 1503–1510 (2011). https://doi.org/10.2337/dc10-1937
A. Colosimo, V. Guida, L. Rigoli, C. Di Bella, A. De Luca, S. Briuglia, L. Stuppia, D.C. Salpietro, B. Dallapiccola, Molecular detection of novel WFS1 mutations in patients with Wolfram syndrome by a DHPLC-based assay. Hum. Mutat. 21(6), 622–629 (2003). https://doi.org/10.1002/humu.10215
J.M. van ven Ouweland, K. Cryns, R.J. Pennings, I. Walraven, G.M. Janssen, J.A. Maassen, B.F. Veldhuijzen, A.B. Arntzenius, D. Lindhout, C.W. Cremers, G. Van Camp, L.D. Dikkeschei, Molecular characterization of WFS1 in patients with Wolfram syndrome. J. Mol. Diagn. 5(2), 88–95 (2003)
A. Colosimo, V. Guida, L. Rigoli, C. Di Bella, A. De Luca, S. Briuglia, L. Stuppia, D.C. Salpietro, B. Dallapiccola, Molecular detection of novel WFS1 mutations in patients with Wolfram syndrome by a DHPLC-based assay. Hum. Mutat. 21(6), 622–629 (2003). https://doi.org/10.1002/humu.10215
C.J. Smith, P.A. Crock, B.R. King, C.J. Meldrum, R.J. Scott, Phenotype-genotype correlations in a series of wolfram syndrome families. Diabetes Care 27(8), 2003–2009 (2004)
F.M. Elli, S. Ghirardello, C. Giavoli, S. Gangi, L. Dioni, M. Crippa, P. Finelli, S. Bergamaschi, F. Mosca, A. Spada, P. Beck-Peccoz, A new structural rearrangement associated to Wolfram syndrome in a child with a partial phenotype. Gene 509(1), 168–172 (2012). https://doi.org/10.1016/j.gene.2012.06.077
S.A. Yuca, N.D. Rendtorff, H. Boulahbel, M. Lodahl, L. Tranebjaerg, Y. Cesur, M. Dogan, C. Yilmaz, C. Akgun, M. Acikgoz, Rapidly progressive renal disease as part of Wolfram syndrome in a large inbred Turkish family due to a novel WFS1 mutation (p.Leu511Pro). Eur. J. Med. Genet. 55(1), 37–42 (2012). https://doi.org/10.1016/j.ejmg.2011.08.005
Aloi, C., Salina, A., Pasquali, L., Lugani, F., Perri, K., Russo, C., Tallone, R., Ghiggeri, G. M., Lorini, R., d’Annunzio, G., Wolfram syndrome: new mutations, different phenotype. PloS ONE 7(1) (2012). https://doi.org/10.1371/journal.pone.0029150
M.A. Ganie, B.A. Laway, S. Nisar, M.M. Wani, M.L. Khurana, F. Ahmad, S. Ahmed, P. Gupta, I. Ali, I. Shabir, A. Shadan, A. Ahmed, S. Tufail, Presentation and clinical course of Wolfram (DIDMOAD) syndrome from North India. Diabet. Med. 28(11), 1337–1342 (2011). https://doi.org/10.1111/j.1464-5491.2011.03377.x
G. Yu, M.L. Yu, J.F. Wang, C.R. Gao, Z.J. Chen, WS1 gene mutation analysis of Wolfram syndrome in a Chinese patient and a systematic review of literatures. Endocrine 38(2), 147–152 (2010). https://doi.org/10.1007/s12020-010-9350-4
A. Zmyslowska, M. Borowiec, K. Antosik, M. Szalecki, A. Stefanski, B. Iwaniszewska, M. Jedrzejczyk, I. Pietrzak, W. Mlynarski, Wolfram syndrome in the Polish population: novel mutations and genotype-phenotype correlation. Clin. Endocrinol. 75(5), 636–641 (2011). https://doi.org/10.1111/j.1365-2265.2011.04102.x
M.U. Aluclu, M. Bahceci, A. Tuzcu, S. Arikan, D. Gokalp, A new mutation in WFS1 gene (C.1522-1523delTA, Y508fsX421) may be responsible for early appearance of clinical features of Wolfram syndrome and suicidal behaviour. Neuro Endocrinol. Lett. 27(6), 691–694 (2006)
F. Giuliano, S. Bannwarth, S. Monnot, A. Cano, B. Chabrol, B. Vialettes, B. Delobel, V. Paquis-Flucklinger, French Group of, W.S.: Wolfram syndrome in French population: characterization of novel mutations and polymorphisms in the WFS1 gene. Hum. Mutat. 25(1), 99–100 (2005). https://doi.org/10.1002/humu.9300
E. Domenech, M. Gomez-Zaera, V. Nunes, Study of the WFS1 gene and mitochondrial DNA in Spanish Wolfram syndrome families. Clin. Genet. 65(6), 463–469 (2004). https://doi.org/10.1111/j.1399-0004.2004.00249.x
P. Zalloua, S.T. Azar, M. Delepine, N.J. Makhoul, H. Blanc, M. Sanyoura, A. Lavergne, K. Stankov, A. Lemainque, P. Baz, C. Julier, WFS1 mutations are frequent monogenic causes of juvenile-onset diabetes mellitus in Lebanon. Hum. Mol. Genet. 17(24), 4012–4021 (2008). https://doi.org/10.1093/hmg/ddn304
J.C. Zenteno, G. Ruiz, H.J. Perez-Cano, M. Camargo, Familial Wolfram syndrome due to compound heterozygosity for two novel WFS1 mutations. Mol. Vis. 14(163), 1353–1357 (2008)
M.R. Gasparin, F. Crispim, S.L. Paula, M.B. Freire, I.S. Dalbosco, T.D. Manna, J.E. Salles, F. Gasparin, A. Guedes, J.M. Marcantonio, M. Gambini, C.P. Salim, R.S. Moises, Identification of novel mutations of the WFS1 gene in Brazilian patients with Wolfram syndrome. Eur. J. Endocrinol. 160(2), 309–316 (2009). https://doi.org/10.1530/EJE-08-0698
C. Hardy, F. Khanim, R. Torres, M. Scott-Brown, A. Seller, J. Poulton, D. Collier, J. Kirk, M. Polymeropoulos, F. Latif, T. Barrett, Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1. Am. J. Hum. Genet. 65(5), 1279–1290 (1999). https://doi.org/10.1086/302609
Acknowledgements
The current study was supported by a grant from Tehran University of Medical Sciences.
Funding
This study was funded by a grant from Tehran University of Medical Sciences.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sobhani, M., Amin Tabatabaiefar, M., Ghafouri-Fard, S. et al. Clinical and molecular assessment of 13 Iranian families with Wolfram syndrome. Endocrine 66, 185–191 (2019). https://doi.org/10.1007/s12020-019-02004-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-019-02004-w